Cermak Elizabeth Insider Trades

Insider Trading History

Track insider trading activity for Cermak Elizabeth. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Moleculin Biotech
Moleculin Biotech MBRX
Director
Holding Value $405k 164,668 shares
Last Trade
Nov 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.83M 150,000 shares
$12.19
$2.46
Moleculin Biotech
Moleculin Biotech MBRX
Director
Holding Value $36.1k 14,668 shares
Last Trade
Nov 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.5k 10,000 shares
$2.45
$2.46
Moleculin Biotech
Moleculin Biotech MBRX
Director
Holding Value $172k 70,000 shares
Last Trade
May 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.3k 15,000 shares
$0.62
$2.46
Moleculin Biotech
Moleculin Biotech MBRX
Director
Holding Value $135k 55,000 shares
Last Trade
Jun 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.5M 61,666 shares
$558.75
$2.46
Clarus Therapeutics Holdings
Clarus Therapeutics Holdings CRXT
Director
Holding Value $274 5,766 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$834 1,922 shares
$0.43
$0.05
Clarus Therapeutics Holdings
Clarus Therapeutics Holdings CRXT
Director
Holding Value $456 9,610 shares
Last Trade
Dec 12, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$64.3k 13,454 shares
$4.78
$0.05
Moleculin Biotech
Moleculin Biotech MBRX
Director
Holding Value $41k 16,667 shares
Last Trade
Jun 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.8M 10,000 shares
$1,481.25
$2.46
Moleculin Biotech
Moleculin Biotech MBRX
Director
Holding Value $98.4k 40,000 shares
Last Trade
Oct 02, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.8M 40,000 shares
$1,819.50
$2.46

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up